Polymyxin overuse requires special monitoring: Need an action |Biomedgrid

Recently guidelines were published emphasizing the restriction of polymyxin use. The polymyxin antibiotics colistin (polymyxin E) and polymyxin B are available since the 1950s. Their use in clinical settings for untreatable Gram-negative infection is in practice globally [1]. Due to the lack of proper Pharmacy services the infections after surgeries increased day by day and are still ignored in developing countries. The practice of guidelines for surgical patients and proper use of antibiotics by Pharmacists' directions are the need of time and as per the physician's prescription. Reference the above guidelines third world countries should have the very basic guidelines for the surgical procedure, especially the KUNIN criteria for the rational use of antibiotics [2]. Patients also used topicals such as the Polymyxin group for surgical infections. In an interventional review in the Cochrane library, the topical antibiotics for preventing surgical site infection in wounds healing by primary intention also show the use of polymyxin in SSI prevention [3]. The only way to restrict the polymyxin is to implement the guidelines such as KUNIN might be helpful in the assessment of rational antibiotics prescription and the misuse of antibiotics would be minimized [4]. By implementation of a robust protocol before and after surgery can assist in minimizing and preventing these SSIs [5].